ARCHIVES

Battelle Wins Big Toxiology Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 07 | March 22, 1974

Download PDF Visit The Full Archive

Related Articles

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

DCCP Board Oks Fur New Concepts

July 17, 1981

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012